SCHEMBL19844329

SCHEMBL19844329

Cc1ccc2c(c1)-c1cc3c4ccccc4n(-c4ccccc4)c3cc1C2(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.46
▸ ATM Q13315 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ HTR2A P28223 1/20 0.34
▸ HTR2C P28335 1/20 0.34
▸ PDK2 Q15119 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ MAPK8 P45983 1/20 0.32
▸ HTT P42858 2/20 0.32
▸ LMNA P02545 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ NTRK1 P04629 1/20 0.32
▸ TDO2 P48775 1/20 0.32
▸ IDO2 Q6ZQW0 1/20 0.32
▸ PGR P06401 3/20 0.32
▸ RXFP1 Q9HBX9 1/20 0.31
▸ PLA2G2A P14555 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19011147 0.92 KDM4E (0.46) KDM4EATML3MBTL1PDK2ALDH1A1
SCHEMBL802130 0.91 KDM4E (0.56) KDM4EATML3MBTL1ALDH1A1MAPK8
SCHEMBL801946 0.89 KDM4E (0.55) KDM4EATML3MBTL1ALDH1A1MAPK8
SCHEMBL14822438 0.89 KDM4E (0.55) KDM4EATML3MBTL1ALDH1A1MAPK8
SCHEMBL783308 0.88 KDM4E (0.50) KDM4EATML3MBTL1ALDH1A1MAPK8
SCHEMBL15040987 0.87 PGR (0.36) KDM4EATML3MBTL1PDK2ALDH1A1
SCHEMBL14682559 0.87 KDM4E (0.46) KDM4EATML3MBTL1PDK2ALDH1A1
SCHEMBL15040988 0.87 PGR (0.36) KDM4EATML3MBTL1PDK2ALDH1A1
SCHEMBL31681 0.87 PGR (0.42) KDM4EATML3MBTL1PDK2HTT
SCHEMBL18381855 0.87 KDM4E (0.49) KDM4EATML3MBTL1ALDH1A1MAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3257093-B1 ELECTRONIC DEVICE CONTAINING CYCLIC LACTAMS MERCK PATENT GMBH (DE) 2021-07-07 — — EP disclosed
US-10249831-B2 Electronic device containing cyclic lactams MERCK PATENT GMBH (DE) 2019-04-02 — — US disclosed
US-20180040832-A1 ELECTRONIC DEVICE CONTAINING CYCLIC LACTAMS MERCK PATENT GMBH (DE) 2018-02-08 — — US disclosed
US-20180040832-A1 ELECTRONIC DEVICE CONTAINING CYCLIC LACTAMS MERCK PATENT GMBH (DE) 2018-02-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10249831-B2 Electronic device containing cyclic lactams OXA1L, UROD, MRPL21 KDM4E 2116/4885ATM 3206/4885L3MBTL1 3138/4885
US-20180040832-A1 ELECTRONIC DEVICE CONTAINING CYCLIC LACTAMS OXA1L, UROD, MRPL21 KDM4E 2116/4885ATM 3206/4885L3MBTL1 3138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback